Pharmaceutical News

F.D.A. Vote Is Minor Victory for Troubled Diabetes Drug

New York Times 2013-06-10
U.S. House approves bill on prescription drug tracking

Reuters 2013-06-04
Shares of Merck, Bristol Jump on Cancer Drug News

New York Times 2013-06-03
Pressure Grows to Create Drugs for ‘Superbugs’

New York Times 2013-06-03
Merck Has Solid Results in a Cancer Drug Trial

New York Times 2013-06-03
ASCO: Sorafenib Halts Resistant Thyroid Cancer

Medpage Today 2013-06-03
Doctor’s Doubts Imperil a Lucrative Diabetes Drug

New York Times 2013-05-30
Asfotase Alfa Granted Breakthrough Status By FDA For Treatment of Childhood Bone-Softening Disease, Hypophosphatasia

Medical Daily 2013-05-29
Azithromycin May Reduce COPD Flare-Ups

Medpage Today 2013-05-28
FDA Panels Backs Merck's Insomnia Drug

Medpage Today 2013-05-23
Senate Committee Approves Bill on Compounding

New York Times 2013-05-23
FDA Approves Once-Daily COPD Drug

Medpage Today 2013-05-10
US judge upholds patent on Shire's Lialda, delaying generic versions until 2020

FirstWord Pharma 2013-05-10
Prices Cut for Cervical Cancer Vaccines for Neediest

New York Times 2013-05-09
Celgene, Concert in $300M+ Deuterium Drug Collaboration

GenNews 2013-05-07
Facing Black Market, Pfizer Sells Viagra on Web

New York Times 2013-05-07
Drug to Cut Cholesterol Is Approved by the F.D.A.

New York Times 2013-05-06
Cancer Physicians Attack High Drug Costs

New York Times 2013-04-25
Opko Health acquires Prolor Biotech for $480m

Bio SmartBrief 2013-04-25
Warner Chilcott Gets FDA Approval for Minastrin 24 FE Oral Contraceptive

Wall Street Journal 2013-04-23

Blogs

The Future of Medicare Advantage

By: Jean LeMasurier

6/18/2013 | 11 reads | 0 comments

Appreciating AMCP

By: Norm Smith

5/17/2013 | 253 reads | 0 comments

Medicare Essential – Is this the future of Medicare?

By: William MacBain

5/15/2013 | 261 reads | 0 comments

Managed Care Poll

Clinical Events Calendar

ADA 73rd Scientific Sessions

Fri, 06/21/2013 - Tue, 06/25/2013
Chicago, Illinois, United States

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications